Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 36.36
+2.48 (7.32%)
Sep 1, 2026, 4:08 PM HKT
Genscript Biotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 196.36 | 142.49 | 131.99 | 1,446 | 1,024 | 1,181 |
Short-Term Investments | 235.19 | 170.02 | 264.37 | 376.22 | 228.89 | 222.53 |
Trading Asset Securities | 378.72 | 499.71 | 224.87 | 105.3 | 210.82 | 2.21 |
Cash & Short-Term Investments | 810.27 | 812.22 | 621.24 | 1,928 | 1,464 | 1,406 |
Cash Growth | -13.65% | 30.74% | -67.78% | 31.71% | 4.13% | 82.00% |
Accounts Receivable | 156.8 | 133.93 | 116.29 | 218.83 | 104.28 | 142.44 |
Other Receivables | - | 25.09 | 19.84 | 80.66 | 66.13 | 22.46 |
Receivables | 156.8 | 159.03 | 136.13 | 299.53 | 170.44 | 166.58 |
Inventory | 45.25 | 39.59 | 31.1 | 53.35 | 59.94 | 44.36 |
Prepaid Expenses | 45.86 | 2.92 | 2.93 | 1.99 | 2.13 | 5.48 |
Restricted Cash | 21.03 | 31.13 | 17.92 | 33.07 | 27.2 | 1.44 |
Other Current Assets | 34.66 | 34.09 | 25.67 | 37.25 | 41.53 | 15.49 |
Total Current Assets | 1,114 | 1,079 | 834.98 | 2,353 | 1,765 | 1,639 |
Property, Plant & Equipment | 639.01 | 612.69 | 595.62 | 728.73 | 624.67 | 486.91 |
Long-Term Investments | 2,987 | 3,111 | 3,790 | 85.41 | 16.03 | 18.47 |
Goodwill | 1.41 | 1.37 | 1.34 | 1.36 | 2.55 | 14.15 |
Other Intangible Assets | 13.38 | 13.25 | 13.04 | 18.65 | 23.81 | 26.42 |
Long-Term Accounts Receivable | - | - | - | 0.29 | 0.4 | - |
Long-Term Deferred Tax Assets | 12.89 | 16.44 | 27.74 | 16.51 | 15.05 | 5.09 |
Other Long-Term Assets | 20.12 | 19.88 | 15.81 | 183.26 | 98.93 | 43.77 |
Total Assets | 4,787 | 4,853 | 5,278 | 3,387 | 2,546 | 2,234 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 42.32 | 36.79 | 29.84 | 39.96 | 55.76 | 30.18 |
Accrued Expenses | 78.91 | 83.1 | 69.86 | 164.77 | 210.03 | 156.11 |
Short-Term Debt | 193.19 | 194.67 | 88.75 | 56.94 | 33.23 | - |
Current Portion of Long-Term Debt | - | - | - | 0.07 | 0.45 | 0.52 |
Current Portion of Leases | 8.78 | 9.16 | 7.52 | 8.87 | 11.1 | 7.51 |
Current Income Taxes Payable | 8.95 | 28.69 | 9.39 | 18.13 | 16.15 | 15.72 |
Current Unearned Revenue | 66.62 | 50.32 | 47.36 | 98.58 | 44.33 | 35.47 |
Other Current Liabilities | 328.09 | 317.45 | 528.36 | 107.49 | 174.93 | 167.79 |
Total Current Liabilities | 726.85 | 720.17 | 781.07 | 494.81 | 545.98 | 413.31 |
Long-Term Debt | 90.07 | 85.93 | 96.74 | 712.72 | 567.23 | 381.86 |
Long-Term Leases | 51.5 | 55.01 | 56.99 | 63.91 | 44.01 | 27.35 |
Long-Term Unearned Revenue | 12.62 | 12.17 | 13.03 | 64.68 | 2.01 | 15.54 |
Long-Term Deferred Tax Liabilities | 12.03 | 14.01 | 5.84 | 5.62 | 8.01 | 7.73 |
Other Long-Term Liabilities | 1.29 | 1.3 | 1.24 | 1.21 | 16.48 | 0.4 |
Total Liabilities | 894.36 | 888.59 | 954.91 | 1,343 | 1,184 | 846.18 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2.19 | 2.19 | 2.14 | 2.12 | 2.11 | 2.1 |
Additional Paid-In Capital | - | 1,988 | 1,982 | 1,939 | 1,473 | 1,274 |
Retained Earnings | - | 1,831 | 2,364 | -597.73 | -502.25 | -275.4 |
Treasury Stock | -2.26 | -3.83 | -6.09 | -9.45 | -11.92 | -15.75 |
Comprehensive Income & Other | 3,888 | 142.14 | -20.56 | 56.87 | 49.57 | 60.78 |
Total Common Equity | 3,888 | 3,959 | 4,321 | 1,391 | 1,011 | 1,046 |
Minority Interest | 5.48 | 5.36 | 2.19 | 653.28 | 352.13 | 341.7 |
Shareholders' Equity | 3,893 | 3,965 | 4,323 | 2,044 | 1,363 | 1,388 |
Total Liabilities & Equity | 4,787 | 4,853 | 5,278 | 3,387 | 2,546 | 2,234 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 343.53 | 344.77 | 250 | 842.5 | 656.02 | 417.24 |
Net Cash (Debt) | 466.74 | 467.45 | 371.23 | 1,085 | 807.69 | 988.47 |
Net Cash Growth | 19.73% | 25.92% | -65.80% | 34.38% | -18.29% | 37.79% |
Net Cash Per Share | 0.21 | 0.21 | 0.17 | 0.51 | 0.39 | 0.49 |
Filing Date Shares Outstanding | 2,187 | 2,188 | 2,160 | 2,124 | 2,111 | 2,096 |
Total Common Shares Outstanding | 2,187 | 2,186 | 2,144 | 2,123 | 2,111 | 2,096 |
Working Capital | 387.03 | 358.8 | 53.9 | 1,858 | 1,219 | 1,226 |
Book Value Per Share | 1.78 | 1.81 | 2.02 | 0.66 | 0.48 | 0.50 |
Tangible Book Value | 3,873 | 3,945 | 4,307 | 1,371 | 984.18 | 1,005 |
Tangible Book Value Per Share | 1.77 | 1.80 | 2.01 | 0.65 | 0.47 | 0.48 |
Land | - | 390.96 | 320.67 | 350.49 | 265.52 | 188.58 |
Machinery | - | 380.53 | 311.68 | 319.62 | 257.2 | 224.78 |
Construction In Progress | - | 63.59 | 129.37 | 131.6 | 142.06 | 91.22 |